Lack of probenecid effect on nonrenal excretion of ceftriaxone in anephric patients.
Probenecid has been shown to decrease renal and biliary excretion of organic acids. In a randomized crossover study, the effect of coadministered probenecid on nonrenal excretion of ceftriaxone was studied in six functionally anephric patients in whom ceftriaxone is eliminated exclusively by nonrenal or presumably by biliary excretion. Each patient received 0.5 g IV ceftriaxone without and with probenecid (0.5 g at 10 and 2 hours prior to ceftriaxone and 0.5 g q12h X 3 doses post ceftriaxone). Serial blood samples were collected over 48 hours and plasma analyzed for ceftriaxone by high performance liquid chromatography (HPLC). Pharmacokinetic analysis was based on a model-independent approach. Probenecid did not significantly affect the disposition of ceftriaxone in this study, thus suggesting that nonrenal excretion of ceftriaxone is not inhibited by probenecid.
Patel
I H
IH
Department of Drug Metabolism, Hoffmann-La Roche Inc., Nutley, New Jersey 07110.
Soni
P P
PP
Carbone
J J
JJ
Audet
P R
PR
Morrison
G
G
Gibson
G A
GA
D000328:Adult; D002443:Ceftriaxone / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D002851:Chromatography, High Pressure Liquid; D006801:Humans; D007676:Kidney Failure, Chronic / Q000378:metabolism*; D008875:Middle Aged; D011339:Probenecid / Q000494:pharmacology*; D011897:Random Allocation; D013997:Time Factors
D002443:Ceftriaxone; D011339:Probenecid